Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 25, 2022

SELL
$225.82 - $368.51 $222,206 - $362,613
-984 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $16,642 - $36,335
75 Added 8.25%
984 $379,000
Q2 2021

Jul 19, 2021

BUY
$129.91 - $234.98 $118,088 - $213,596
909 New
909 $260,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.